Volume 41, Issue 2, Pages (August 2004)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced.
The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair  Y. Mifune, T. Matsumoto, K.
Volume 46, Issue 3, Pages (March 2007)
Volume 41, Issue 6, Pages (December 2004)
Journal of Molecular and Cellular Cardiology
Volume 62, Issue 3, Pages (March 2015)
Volume 41, Issue 2, Pages (August 2004)
Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced.
Volume 85, Issue 2, Pages (January 2014)
The Chemopreventive Effect of Tanacetum Polycephalum Against LA7-Induced Breast Cancer in Rats and the Apoptotic Effect of a Cytotoxic Sesquiterpene.
The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair  Y. Mifune, T. Matsumoto, K.
Volume 16, Issue 10, Pages (October 2008)
Loss of Vhl in cartilage accelerated the progression of age-associated and surgically induced murine osteoarthritis  T. Weng, Y. Xie, L. Yi, J. Huang,
Volume 117, Issue 2, Pages (August 1999)
Volume 42, Issue 1, Pages (January 2005)
Duodenal Reflux Leads to Down Regulation of DNA Mismatch Repair Pathway in an Animal Model of Esophageal Cancer  Pramod Bonde, MD, MS, Daqing Gao, PhD,
Volume 41, Issue 2, Pages (August 2004)
Type I IL-1 Receptor Mediates IL-1 and Intracellular IL-1 Receptor Antagonist Effects in Skin Inflammation  Gaby Palmer, Dominique Talabot-Ayer, Gürkan.
Volume 44, Issue 2, Pages (February 2006)
Volume 133, Issue 6, Pages (December 2007)
Volume 64, Issue 1, Pages (January 2016)
Volume 42, Issue 5, Pages (May 2005)
Volume 44, Issue 1, Pages (January 2006)
Volume 42, Issue 1, Pages (January 2005)
Volume 62, Issue 2, Pages (August 2002)
Angiogenesis in liver disease
Volume 50, Issue 4, Pages (April 2009)
Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis  Jung-Yeon Kim, Hyun-Jin An, Woon-Hae.
Volume 65, Issue 4, Pages (October 2016)
Volume 129, Issue 2, Pages (August 2005)
Volume 42, Issue 4, Pages (April 2005)
Volume 114, Issue 3, Pages (March 1998)
Volume 62, Issue 1, Pages (July 2002)
A novel vascularized patch enhances cell survival and modifies ventricular remodeling in a rat myocardial infarction model  Qi Zhou, MD, PhD, Jian-Ye.
Borislava Haralanova-Ilieva, Giuliano Ramadori, Thomas Armbrust 
Volume 42, Issue 2, Pages (February 2005)
Does hemophilia slow down the development of liver fibrosis?
Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease
Comparison of two methods of in vivo gene transfer by electroporation
Volume 69, Issue 2, Pages (August 2018)
Volume 9, Issue 1, Pages (January 2004)
Nitric oxide from rat liver sinusoidal endothelial cells induces apoptosis in IFN γ- sensitized CC531s colon carcinoma cells  Katrien Vekemans, Filip Braet,
Volume 39, Issue 4, Pages (October 2003)
Hepatic hepcidin expression is decreased in cirrhosis and HCC
Role of Connective Tissue Growth Factor in Oval Cell Response During Liver Regeneration After 2-AAF/PHx in Rats  Liya Pi, Seh-Hoon Oh, Thomas Shupe, Bryon.
Volume 134, Issue 4, Pages (April 2008)
Volume 62, Issue 6, Pages (June 2015)
Volume 39, Issue 5, Pages (November 2003)
Volume 65, Issue 2, Pages (August 2016)
Superoxide-induced apoptosis of activated rat hepatic stellate cells
Volume 128, Issue 1, Pages (January 2005)
Volume 127, Issue 3, Pages (September 2004)
Volume 59, Issue 2, Pages (August 2013)
Volume 68, Issue 2, Pages (August 2005)
Volume 41, Issue 6, Pages (December 2004)
Adam Mor, Roni Haklai, Ofer Ben-Moshe, Yoseph A. Mekori, Yoel Kloog 
Volume 42, Issue 6, Pages (June 2005)
Paul C. Adams, James C. Barton  Journal of Hepatology 
Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation  Y. Akasaki, M.D., S. Matsuda,
Domenico Alvaro, Alessandro Gigliozzi, Adolfo F. Attili 
Volume 56, Issue 6, Pages (June 2012)
Volume 44, Issue 2, Pages (February 2006)
Volume 84, Issue 2, Pages (August 2013)
Volume 39, Issue 6, Pages (December 2003)
Volume 62, Issue 3, Pages (March 2015)
Volume 62, Issue 6, Pages (June 2015)
Volume 44, Issue 3, Pages (March 2006)
Volume 61, Issue 2, Pages (August 2014)
Volume 59, Issue 2, Pages (February 2001)
Presentation transcript:

Volume 41, Issue 2, Pages 235-241 (August 2004) Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid  Shimon Reif, Hussein Aeed, Yael Shilo, Reuven Reich, Yoel Kloog, Young Oh Kweon, Rafael Bruck  Journal of Hepatology  Volume 41, Issue 2, Pages 235-241 (August 2004) DOI: 10.1016/j.jhep.2004.04.010

Fig. 1 Liver histology: (A) liver section showing cirrhosis induced after 12 weeks of TAA treatment. H&E, magnification ×80. (B) Liver section showing cirrhosis induced by 12 weeks of TAA administration, after 8 weeks of PBS treatment: no evidence of spontaneous regression. H&E, magnification ×80. (C) Significant regression of hepatic fibrosis in the cirrhotic rats treated with FTS for 8 weeks, after the induction of cirrhosis. H&E, magnification ×80. Journal of Hepatology 2004 41, 235-241DOI: (10.1016/j.jhep.2004.04.010)

Fig. 2 The low activity of MMP-2 and MMP-9 in normal livers (untreated animals) was significantly increased in cirrhotic rats treated with TAA for 12 weeks. Four and eight weeks after TAA discontinuation, MMP activity was decreased in both groups, but the activity of MMP-2 (A, B) and MMP-9 (C, D) in the livers of the FTS-treated rats was significantly higher compared to the PBS-treated rats. N=5 in each group, mean±SD, ∗∗P<0.01 compared to normal and to TAA+PBS. Journal of Hepatology 2004 41, 235-241DOI: (10.1016/j.jhep.2004.04.010)

Fig. 3 Examples of apoptotic cells by TUNEL assay: (A) negative control. (B) No TUNEL positive cells. Livers with cirrhosis induced after 12 weeks of TAA treatment. (C) TUNEL positive cell at the center of the field (deep blue nucleus). TAA 12 weeks+PBS for 8 weeks. (D) TUNEL positive cells at upper and lower ends of the field. TAA 12 weeks+FTS 8 weeks (×80). (D2): immunohistochemical staining for α smooth muscle actin, demonstrating that the TUNEL-positive cells represent activated HSC. Journal of Hepatology 2004 41, 235-241DOI: (10.1016/j.jhep.2004.04.010)

Fig. 4 Quantification of cell apoptotic figures during recovery from TAA-induced liver cirrhosis. Cell apoptotic figures were quantified in liver sections from the various treatment groups 8 weeks after TAA withdrawal. Mean±SD, n=3. Journal of Hepatology 2004 41, 235-241DOI: (10.1016/j.jhep.2004.04.010)

Fig. 5 The expression of TIMP-2 in the rat livers of the various groups was measured 4 and 8 weeks after TAA withdrawal in different groups of rats using RT-PCR. As shown, FTS administration caused a marked increase in the expression of TIMP-2, both after 4 and 8 weeks of TAA withdrawal compared to the control group treated with PBS (n=5, ∗P<0.01 compared to normal; ∗∗P<0.01 compared to TAA+PBS). Journal of Hepatology 2004 41, 235-241DOI: (10.1016/j.jhep.2004.04.010)